Redirection of T cells with a first fully humanized bispecific CD33–CD3 antibody efficiently eliminates AML blasts without harming hematopoietic stem cells-Reference-Cited by-同舟云学术

Redirection of T cells with a first fully humanized bispecific CD33–CD3 antibody efficiently eliminates AML blasts without harming hematopoietic stem cells

Published:2013-01-17 Issue:4 Volume:27 Page:964-967
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Arndt C,von Bonin M,Cartellieri M,Feldmann A,Koristka S,Michalk I,Stamova S,Bornhäuser M,Schmitz M,Ehninger G,Bachmann M

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201318.pdf

Reference14 articles.

1. Robak T, Wierzbowska A . Current and emerging therapies for acute myeloid leukemia. Clin Ther 2009; 31: 2349–2370.

2. Dinndorf PA, Andrews RG, Benjamin D, Ridgway D, Wolff L, Bernstein ID . Expression of normal myeloid-associated antigens by acute leukemia cells. Blood 1986; 67: 1048–1053.

3. Hauswirth AW, Florian S, Printz D, Sotlar K, Krauth MT, Fritsch G et al. Expression of the target receptor CD33 in CD34+/CD38-/CD123+ AML stem cells. Eur J Clin Invest 2007; 37: 73–82.

4. Horton SJ, Huntly BJ . Recent advances in acute myeloid leukemia stem cell biology. Haematologica 2012; 97: 966–974.

5. Walter RB, Appelbaum FR, Estey EH, Bernstein ID . Acute myeloid leukemia stem cells and CD33-targeted immunotherapy. Blood 2012; 119: 6198–6208.

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing a membrane-proximal CD33-targeting CAR T cell;Journal for ImmunoTherapy of Cancer;2024-05

2. Multi-targeted immunotherapeutics to treat B cell malignancies;Journal of Controlled Release;2023-06

3. Engineering CAR-NK cells targeting CD33 with concomitant extracellular secretion of anti-CD16 antibody revealed superior antitumor effects toward myeloid leukemia;Cancer Letters;2023-04

4. Immune therapy: a new therapy for acute myeloid leukemia;Blood Science;2022-12-15

5. Engineering CAR-NK cells targeting CD33 with concomitant extracellular secretion of anti-CD16 antibody revealed superior antitumor effects toward myeloid leukemia;2022-11-16